Bg pattern

MONTELUKAST TEVA 5 mg CHEWABLE TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MONTELUKAST TEVA 5 mg CHEWABLE TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Montelukast Teva 5 mg Chewable Tablets EFG

Read the entire package leaflet carefully before you or your child take this medicine, as it contains important information for you or your child.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist or your child's doctor or pharmacist.
  • This medicine has been prescribed for you or your child only. Do not give it to others, as it may harm them, even if they have the same symptoms as you or your child.
  • If you or your child experience any side effects, consult your doctor or pharmacist or your child's doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Montelukast Teva and what is it used for
  2. What you need to know before you or your child take Montelukast Teva
  3. How to take Montelukast Teva
  4. Possible side effects
  5. Storage of Montelukast Teva
  6. Contents of the pack and further information

1. What is Montelukast Teva and what is it used for

What is Montelukast Teva

Montelukast is a leukotriene receptor antagonist that blocks substances called leukotrienes.

How Montelukast Teva works

Leukotrienes cause narrowing and swelling of the airways in the lungs. By blocking leukotrienes, montelukast improves asthma symptoms and helps control asthma.

When to use Montelukast Teva

Your doctor or your child's doctor has prescribed montelukast chewable tablets to treat asthma, preventing asthma symptoms during the day and night.

  • Montelukast is used to treat pediatric patients from 6 to 14 years of age who are not adequately controlled with their medication and need additional treatment.
  • Montelukast is also used as an alternative treatment to inhaled corticosteroids in patients between 6 and 14 years of age who have not recently taken oral corticosteroids for the treatment of their asthma and have demonstrated that they are unable to use inhaled corticosteroids.
  • Montelukast helps prevent narrowing of the airways caused by exercise.

Depending on the symptoms and severity of asthma in you or your child, your doctor will determine how to use montelukast.

What is asthma?

Asthma is a chronic disease.

Asthma includes:

  • difficulty breathing due to narrowing of the airways. This narrowing of the airways worsens and improves in response to various diseases.
  • airways that are sensitive to many things, such as cigarette smoke, pollen, cold air, or exercise.
  • swelling (inflammation) of the inner layer of the airways.

Asthma symptoms include: coughing, wheezing, and chest congestion.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you or your child take Montelukast Teva

Tell your doctor about any allergy or medical problem that you or your child have now or have had.

Do not take Montelukast Teva chewable tablets

  • If you or your child are allergic to montelukast or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before you or your child take Montelukast Teva 5 mg chewable tablets.

  • If your asthma or breathing or your child's asthma or breathing worsen, inform your doctor or your child's doctor immediately.
  • Montelukast is not indicated for the treatment of acute asthma attacks. If an attack occurs, follow the instructions given by your doctor for you or your child. Always have your child's or your rescue inhaler medication available for asthma attacks.
  • It is essential that you or your child use all asthma medications prescribed by your doctor. Montelukast Teva should not be used instead of other asthma medications that your doctor has prescribed for your child.
    • If you or your child are being treated with asthma medications, you should be aware that if you develop a combination of symptoms such as flu-like illness, tingling or numbness of arms or legs, worsening of lung symptoms, and/or skin rash, you should consult your doctor or your child's doctor.
    • You or your child should not take acetylsalicylic acid (aspirin) or anti-inflammatory medications (also known as non-steroidal anti-inflammatory medications or NSAIDs) if they worsen your asthma.
    • If you or your child have phenylketonuria, you should know that Montelukast Teva chewable tablets contain aspartame, which is a source of phenylalanine. The phenylalanine in the tablets may be harmful to patients with phenylketonuria.

Several neuropsychiatric events (e.g., changes in behavior and mood-related events, depression, and suicidal tendencies)have been reported in patients of all ages treated with montelukast (see section 4). If you or your child develop these symptoms while taking Montelukast chewable tablets, you should contact your doctor or your child's doctor.

Children and adolescents

Do not give this medicine to children under 6 years of age.

For pediatric patients under 18 years of age, other presentations of this medicine are available based on the age range.

Taking Montelukast Teva with other medicines

Tell your doctor, your child's doctor, or pharmacist if you or your child are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.

Some medicines may affect the way montelukast works, or montelukast may affect the way other medicines work.

Before taking Montelukast Teva, tell your doctor if you or your child are taking the following medicines:

  • phenobarbital (used to treat epilepsy).
  • phenytoin (used to treat epilepsy).
  • rifampicin (used to treat tuberculosis and some other infections).
  • gemfibrozil (used to treat hypertriglyceridemia, hyperlipidemia, and primary hypercholesterolemia).

Taking Montelukast Teva 5 mg with food and drinks

Montelukast Teva chewable tablets should not be taken with food; they should be taken at least 1 hour before or 2 hours after food.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Pregnancy

Your doctor will assess whether you can take montelukast during this period.

Breastfeeding

It is unknown whether montelukast chewable tablets appear in breast milk. If you are breastfeeding or plan to breastfeed, you should consult your doctor before taking montelukast chewable tablets.

Driving and using machines

Montelukast is not expected to affect your ability to drive a car or operate machines. However, individual responses to the medicine may vary. Certain side effects (such as dizziness and somnolence) that have been reported with montelukast may affect the patient's ability to drive or operate machines.

Montelukast Teva contains aspartame

This medicine contains 0.5 mg of aspartame in each chewable tablet.

Aspartame contains a source of phenylalanine that may be harmful in cases of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly.

Montelukast Teva contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per chewable tablet; it is essentially "sodium-free".

3. How to take Montelukast Teva

Follow the instructions for administration of this medicine exactly as indicated by your doctor, your child's doctor, or pharmacist for you or your child. If you are unsure, consult your doctor, your child's doctor, or pharmacist again.

  • You or your child should only take one montelukast chewable tablet once a day, as prescribed by your doctor.
  • It should be taken even when you or your child do not have symptoms or when you or your child have an acute asthma attack.

For children from 6 to 14 years of age

The recommended dose is one 5 mg chewable tablet daily in the evening.

If you or your child are taking Montelukast Teva, ensure that neither you nor your child take any other medicine that contains the same active ingredient, montelukast.

This medicine is taken orally.

The tablets should be chewed before swallowing.

Montelukast should not be taken with food; it should be taken at least 1 hour before or 2 hours after food.

If you or your child take more Montelukast Teva than you should

Seek help from your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20. In most cases of overdose, no adverse effects were reported. The symptoms that occurred most frequently in overdose in adults and children were abdominal pain, somnolence, thirst, headache, vomiting, and hyperactivity.

If you or your child forget to take Montelukast Teva chewable tablets

Try to take/give montelukast as prescribed. However, if you or your child forget a dose, just resume the usual routine of one chewable tablet once a day.

Do not take/give a double dose to make up for forgotten doses.

If you or your child stop taking Montelukast Teva chewable tablets

Montelukast may only treat your asthma or your child's asthma if you or your child continue taking it. It is essential that you continue taking montelukast for the time your doctor or your child's doctor prescribes it. It will help control your asthma or your child's asthma.

If you have any further questions about the use of this medicine, ask your doctor, your child's doctor, or pharmacist.

For pediatric patients from 2 to 5 years of age, Montelukast Teva 4 mg chewable tablets are available.

For adult patients 15 years of age and older, Montelukast Teva 10 mg film-coated tablets are available.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

In clinical trials with montelukast 5 mg chewable tablets, the side effects related to the administration of the medicine and reported most frequently (may affect up to 1 in 10 people) were:

  • headache

Additionally, the following side effects were reported in clinical trials with montelukast 10 mg film-coated tablets:

  • abdominal pain

These side effects were generally mild and occurred with a higher frequency in patients treated with montelukast than with placebo (a pill that does not contain medicine).

Serious side effects

Consult your doctor immediatelyif you observe any of the following side effects, which may be serious and you or your child may need urgent medical treatment.

Uncommon (may affect up to 1 in 100 people):

  • allergic reactions including swelling of the face, lips, tongue, and/or throat that may cause difficulty breathing or swallowing
  • behavior and mood-related changes: excitement including aggressive or hostile behavior, depression
  • seizures

Rare (may affect up to 1 in 1,000 people):

  • increased risk of bleeding
  • tremor
  • palpitations

Very rare (may affect up to 1 in 10,000 people):

  • a combination of symptoms such as flu-like illness, tingling or numbness of arms and legs, worsening of lung symptoms, and/or skin rash (Churg-Strauss syndrome) (see section 2)
  • low platelet count
  • behavior and mood-related changes: hallucinations, disorientation, suicidal thoughts and actions
  • inflammation (inflammation) of the lungs
  • severe skin reactions (erythema multiforme) that may occur without warning
  • inflammation of the liver (hepatitis)

Other side effects reported during the marketing of the medicine

Very common (may affect more than 1 in 10 people)

  • upper respiratory tract infection.

Common (may affect up to 1 in 10 people)

  • diarrhea, nausea, and vomiting,
  • skin rash,
  • fever,
  • elevated liver enzymes.

Uncommon (may affect up to 1 in 100 people)

  • behavior and mood-related changes: sleep disturbances, including nightmares, sleepwalking, irritability, anxiety, stress, agitation
  • dizziness, somnolence, tingling/numbness of the extremities
  • nosebleeds,
  • dry mouth, indigestion
  • bruising, itching, urticaria
  • muscle or joint pain, muscle cramps
  • bedwetting (in children)
  • weakness/fatigue, malaise, swelling

Rare (may affect up to 1 in 1,000 people)

  • behavior and mood-related changes: attention disturbance, memory disturbance, uncontrolled muscle movements

Very rare (may affect up to 1 in 10,000 people)

  • red, painful lumps under the skin that most frequently appear on the shins (erythema nodosum)
  • behavior and mood-related changes: obsessive-compulsive symptoms, stuttering

Reporting of side effects:

If you or your child experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines Agency's website: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Montelukast Teva

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date that appears on the blister and on the carton after EXP. The expiry date is the last day of the month indicated.

Do not store above 25°C. Keep the blister in the original packaging to protect it from light.

Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and further information

Composition of Montelukast Teva 5 mg chewable tablets

  • The active ingredient is montelukast. Each chewable tablet contains 5.20 mg of montelukast sodium, equivalent to 5 mg of montelukast.
  • The other ingredients are: mannitol (E421), sodium lauryl sulfate, hydroxypropyl cellulose, red iron oxide (E172), cherry flavor PHS-143671: maltodextrin (corn) and modified starch E1450, aspartame (E951), sodium carboxymethyl starch (corn) (Type A), and magnesium stearate.

Appearance and packaging of the product

The 5 mg chewable tablets are pink, square-shaped, and engraved with "93" on one side and "7425" on the other.

Montelukast Teva 5 mg chewable tablets are available in packs of 7, 14, 15, 20, 28, 30, 50, 56, 60, 90, 98, and 100 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Teva Pharma, S.L.U.

C/ Anabel Segura 11, Edificio Albatros B 1ª planta

28108 Alcobendas, Madrid

Spain

Manufacturer

Teva Pharmaceutical Works Private Limited Company

Pallagi ut 13 (Debrecen) - H-4042

Hungary

or

Pharmachemie B.V.

Swensweg, 5 2031 GA Haarlem

Netherlands

or

Teva Operations Poland Sp. z.o.o.

ul. Mogilska 80, 31-546 Krakow

Poland

This medicine is authorized in the Member States of the European Economic Area under the following names:

Austria: Montelukast ratiopharm 5mg Kautabletten

Czech Republic: Montelukast Teva 5mg

Denmark: Montelukast Teva

Estonia: Montelukast Teva

Spain: Montelukast Teva 5 mg chewable tablets EFG

Finland: Montelukast ratiopharm 5mg, chewable tablets

Hungary: Montelukast Teva 5mg chewable tablets

Ireland: Montelukast Teva 5mg Chewable Tablets

Latvia: Montelukast Teva

Norway: Montelukast Teva 5mg, chewable tablets

Poland: Montelukast Teva, 5 mg, chewable tablets

Portugal: Montelucaste Teva 5 mg Chewable Tablets

Slovakia: Montelukast Teva 5mg

Date of the last revision of this package leaflet: August 2024

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for MONTELUKAST TEVA 5 mg CHEWABLE TABLETS

Discuss questions about MONTELUKAST TEVA 5 mg CHEWABLE TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (760)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for MONTELUKAST TEVA 5 mg CHEWABLE TABLETS?
MONTELUKAST TEVA 5 mg CHEWABLE TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MONTELUKAST TEVA 5 mg CHEWABLE TABLETS?
The active ingredient in MONTELUKAST TEVA 5 mg CHEWABLE TABLETS is montelukast. This information helps identify medicines with the same composition but different brand names.
How much does MONTELUKAST TEVA 5 mg CHEWABLE TABLETS cost in pharmacies?
The average pharmacy price for MONTELUKAST TEVA 5 mg CHEWABLE TABLETS is around 21.06 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures MONTELUKAST TEVA 5 mg CHEWABLE TABLETS?
MONTELUKAST TEVA 5 mg CHEWABLE TABLETS is manufactured by Teva Pharma S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MONTELUKAST TEVA 5 mg CHEWABLE TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MONTELUKAST TEVA 5 mg CHEWABLE TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MONTELUKAST TEVA 5 mg CHEWABLE TABLETS?
Other medicines with the same active substance (montelukast) include MONKASTA 10 mg FILM-COATED TABLETS, MONKASTA 4 mg CHEWABLE TABLETS, MONKASTA 5 mg CHEWABLE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media